D Medical Limited - Accounts to registrar (filleted) - small 18.2

D Medical Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v20.2.0.366 09364536 director 1.4.19 31.3.20 31.3.20 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure093645362019-03-31093645362020-03-31093645362019-04-012020-03-31093645362018-03-31093645362018-04-012019-03-31093645362019-03-3109364536ns16:EnglandWales2019-04-012020-03-3109364536ns15:PoundSterling2019-04-012020-03-3109364536ns11:Director12019-04-012020-03-3109364536ns11:PrivateLimitedCompanyLtd2019-04-012020-03-3109364536ns11:SmallEntities2019-04-012020-03-3109364536ns11:AuditExempt-NoAccountantsReport2019-04-012020-03-3109364536ns11:SmallCompaniesRegimeForDirectorsReport2019-04-012020-03-3109364536ns11:SmallCompaniesRegimeForAccounts2019-04-012020-03-3109364536ns11:FullAccounts2019-04-012020-03-3109364536ns11:OrdinaryShareClass12019-04-012020-03-3109364536ns11:CompanySecretary12019-04-012020-03-3109364536ns11:RegisteredOffice2019-04-012020-03-3109364536ns6:CurrentFinancialInstruments2020-03-3109364536ns6:CurrentFinancialInstruments2019-03-3109364536ns6:ShareCapital2020-03-3109364536ns6:ShareCapital2019-03-3109364536ns6:RetainedEarningsAccumulatedLosses2020-03-3109364536ns6:RetainedEarningsAccumulatedLosses2019-03-3109364536ns6:ComputerEquipment2019-03-3109364536ns6:ComputerEquipment2019-04-012020-03-3109364536ns6:ComputerEquipment2020-03-3109364536ns6:ComputerEquipment2019-03-3109364536ns6:CostValuation2019-03-3109364536ns6:CurrentFinancialInstrumentsns6:WithinOneYear2020-03-3109364536ns6:CurrentFinancialInstrumentsns6:WithinOneYear2019-03-3109364536ns6:DeferredTaxation2019-03-3109364536ns6:DeferredTaxation2019-04-012020-03-3109364536ns6:DeferredTaxation2020-03-3109364536ns11:OrdinaryShareClass12020-03-31
REGISTERED NUMBER: 09364536 (England and Wales)












UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2020

FOR

D MEDICAL LIMITED

D MEDICAL LIMITED (REGISTERED NUMBER: 09364536)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2020










Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


D MEDICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2020







DIRECTOR: Mr D A Smith





SECRETARY: Mr D A Smith





REGISTERED OFFICE: Fifth Floor
11 Leadenhall Street
London
EC3V 1LP





REGISTERED NUMBER: 09364536 (England and Wales)





ACCOUNTANTS: Acuity Professional Ltd
Business Advisers and Accountants
Fifth Floor
11 Leadenhall Street
London
EC3V 1LP

D MEDICAL LIMITED (REGISTERED NUMBER: 09364536)

STATEMENT OF FINANCIAL POSITION
31 MARCH 2020

2020 2019
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 7,748 9,246
Investments 5 5,000 5,000
12,748 14,246

CURRENT ASSETS
Debtors 6 139,119 81,409
Cash at bank and in hand 55,421 48,424
194,540 129,833
CREDITORS
Amounts falling due within one year 7 13,813 56,604
NET CURRENT ASSETS 180,727 73,229
TOTAL ASSETS LESS CURRENT
LIABILITIES

193,475

87,475

PROVISIONS FOR LIABILITIES 8 1,472 1,756
NET ASSETS 192,003 85,719

CAPITAL AND RESERVES
Called up share capital 9 1 1
Retained earnings 192,002 85,718
SHAREHOLDERS' FUNDS 192,003 85,719

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2020.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2020 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act
2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

D MEDICAL LIMITED (REGISTERED NUMBER: 09364536)

STATEMENT OF FINANCIAL POSITION - continued
31 MARCH 2020


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Comprehensive Income has not been delivered.

The financial statements were approved by the director and authorised for issue on 11 September 2020 and were signed
by:





Mr D A Smith - Director


D MEDICAL LIMITED (REGISTERED NUMBER: 09364536)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2020


1. STATUTORY INFORMATION

D Medical Limited is a private company, limited by shares , registered in England and Wales. The company's
registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The preparation of financial statements in conformity with FRS 102 section 1A requires the use of certain critical
accounting estimates. lt also requires management to exercise judgement in applying the company's accounting
policies.

SIGNIFICANT JUDGEMENTS AND ESTIMATES
In preparing the financial statements, management were not required to make any estimates or judgements which
materially affect reported income, expenses, assets, liabilities or disclosure of contingent assets and liabilities.

TURNOVER
Turnover comprises the value of consideration receivable from the customer for the rendering of services, net of
value-added tax (VAT) rebates and discounts.

D MEDICAL LIMITED (REGISTERED NUMBER: 09364536)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2020


2. ACCOUNTING POLICIES - continued

FINANCIAL INSTRUMENTS
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other
Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognized in the company's balance sheet when the company becomes party to the
contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is
a legally enforceable right to set off the recognized amounts and there is an intention to settle on a net basis or to
realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction
price including transaction costs and are subsequently carried at amortized cost using the effective interest method
unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value
of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one
year are not amortized.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual
arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of
the company after deducting all of its liabilities.

Basic financial liabilities
Basic financial liabilities, including creditors and bank loans that are classified as debt, are initially recognized at
transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is
measured at the present value of the future payment discounted at a market rate of interest. Financial liabilities
classified as payable within one year are not amortized.

Debt instruments are subsequently carried at amortized cost, using the effective interest rate method.

TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the
extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or
substantively enacted by the statement of financial position date.


D MEDICAL LIMITED (REGISTERED NUMBER: 09364536)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2020


2. ACCOUNTING POLICIES - continued
DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement
of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from
those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that
have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the
timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they
will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

RESEARCH AND DEVELOPMENT
Research and development expenditure is written off in the profit and loss account in the year to which the
expenditure relates. The tax relief on research and development expenditure will be recognised in the financial
statements in the year it has been approved by HMRC.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer and office equipment 25% on reducing balance

The assets residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if
appropriate, or if there is an indication of a significant change since the last reporting date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2019 - 4 ) .

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
Cost
At 1 April 2019 14,404
Additions 999
At 31 March 2020 15,403
Depreciation
At 1 April 2019 5,158
Charge for year 2,497
At 31 March 2020 7,655
Net book value
At 31 March 2020 7,748
At 31 March 2019 9,246

D MEDICAL LIMITED (REGISTERED NUMBER: 09364536)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2020


5. FIXED ASSET INVESTMENTS
Other
investments
£   
Cost
At 1 April 2019
and 31 March 2020 5,000
Net book value
At 31 March 2020 5,000
At 31 March 2019 5,000

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2020 2019
£    £   
Trade debtors 115,495 81,409
Loan account 20,000 -
Prepayments 3,624 -
139,119 81,409

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2020 2019
£    £   
Trade creditors 110 100
Taxation and social security 2,455 21,420
Other creditors 11,248 35,084
13,813 56,604

8. PROVISIONS FOR LIABILITIES
2020 2019
£    £   
Deferred tax 1,472 1,756

Deferred
tax
£   
Balance at 1 April 2019 1,756
Provided during year (284 )
Balance at 31 March 2020 1,472

D MEDICAL LIMITED (REGISTERED NUMBER: 09364536)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2020


9. CALLED UP SHARE CAPITAL


Allotted, issued and fully paid:
Number: Class: Nominal 2020 2019
value: £    £   
1 Ordinary £1 1 1

10. ULTIMATE CONTROLLING PARTY

Mr. D A Smith is the ultimate controlling party by virtue of his shareholdings.